
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Dopamine
Therapeutic Area : Neurology
Study Phase : Phase I/ Phase II
Recipient : University Hospital, Lille
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Dopamine is a Hormone drug candidate, which is currently being evaluated in Phase I/ Phase II clinical studies for the treatment of Parkinson Disease.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
October 09, 2025
Lead Product(s) : Dopamine
Therapeutic Area : Neurology
Highest Development Status : Phase I/ Phase II
Recipient : University Hospital, Lille
Deal Size : Inapplicable
Deal Type : Inapplicable
